Based on the meta-analysis of Andersen et al., prevalence estimates of MAFLD in clinical studies performed on children and adolescents with obesity, as well as in those from the general population, were significantly lower when using elevated ALT as a diagnostic tool rather than liver biopsy, ultrasound, or MRI [12]. This evidence concerns the gene GPT and obesity disorder.